To further determine whether CTLs’ reaction was specific to tumor cells, we further evaluated CD8+ T cell activation in an OT-1 TCR transgenic mouse model, in which the CD8+ T cells express a T cell receptor recognizing the SIINFEKL peptide of ovalbumin (OVA) (Wang et al., 2020). This evidence concerns the gene TBXT and neoplasm.